头蛋白(NOG)活性蛋白
Active Noggin (NOG)
SYM1; SYNS1; Synostoses(Multiple)Syndrome 1; Symphalangism 1(Proximal)
- 编号APC130Hu01
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 缓冲液成份20mM Tris, 150mM NaCl缓冲液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性状冻干粉
- 纯度> 95%
- 等电点9.1
- 应用Cell culture; Activity Assays.
- 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1330 ¥ 3324 ¥ 6648 ¥ 19944 ¥ 49860
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
活性实验
Figure. The binding activity of NOG with CDF5.
Noggin, also known as NOG, is a protein that is involved in the development of many body tissues, including nerve tissue, muscles, and bones. Noggin is a signaling molecule that plays an important role in promoting somite patterning in the developing embryo. It is released from the notochord and regulates bone morphogenic protein (BMP4) during development. It also causes formation of the head and other dorsal structures. Besides, Growth Differentiation Factor 5 (GDF5) has been identified as an interactor of NOG, thus a binding ELISA assay was conducted to detect the interaction of recombinant human NOG and recombinant human CDF5. Briefly, NOG were diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100uL were then transferred to CDF5-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-NOG pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50µL stop solution to the wells and read at 450nm immediately. The binding activity of NOG and CDF5 was shown in Figure 1, and this effect was in a dose dependent manner.
用法
Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
APC130Hu01 | 头蛋白(NOG)活性蛋白 | Cell culture; Activity Assays. |
RPC130Hu01 | 头蛋白(NOG)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC130Hu02 | 头蛋白(NOG)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPC130Hu61 | 头蛋白(NOG)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC130Hu01 | 头蛋白(NOG)多克隆抗体 | WB; IHC; ICC; IP. |
PAC130Hu02 | 头蛋白(NOG)多克隆抗体 | WB; IHC; ICC; IP. |
LAC130Hu71 | 头蛋白(NOG)多克隆抗体(生物素标记) | WB; IHC; ICC. |
LAC130Hu81 | 头蛋白(NOG)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
MAC130Hu21 | 头蛋白(NOG)单克隆抗体 | WB; IHC; ICC; IP. |
MAC130Hu22 | 头蛋白(NOG)单克隆抗体 | WB,IHC |
MAC130Hu24 | 头蛋白(NOG)单克隆抗体 | WB,IHC |
MAC130Hu26 | 头蛋白(NOG)单克隆抗体 | WB,IHC |
LAC130Hu76 | 头蛋白(NOG)单克隆抗体(生物素标记) | WB; IHC; ICC. |
SEC130Hu | 头蛋白(NOG)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC130Hu | 头蛋白(NOG)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
PSC130Hu01 | 头蛋白(NOG)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSC130Hu01 | 头蛋白(NOG)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
杂志 | 参考文献 |
Arthritis Rheumatol | Imbalance between BMP2 and Noggin induces abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis [PubMed: 26413886] |
Arthritis Rheumatol. | Imbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal Osteogenic Differentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis [Pubmed:26413886] |
Clin Exp Pharmacol Physiol. | Oxygen-glucose deprivation preconditioning protects neurons against oxygen-glucose deprivation/reperfusion induced injury via bone morphogenetic protein-7 mediated ERK, p38 and Smad signalling pathways. [Pubmed:26385023] |
European cells & materials | The BMP2 variant L51P restores the osteogenic differentiation of human mesenchymal stromal cells in the presence of intervertebral disc cells. [pubmed:28266688] |
Arthritis & Rheumatology | mbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal OsteogenicDifferentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis. [pubmed:26413886] |
Biotechnology and Applied Biochemistry | The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells. [pubmed:28981962] |
Heliyon | Efficient in vitro delivery of Noggin siRNA enhances osteoblastogenesis [pubmed:29167826] |
Journal of Cellular Biochemistry | Low‐intensity pulsed ultrasound promotes bone morphogenic protein 9‐induced osteogenesis and suppresses inhibitory effects of inflammatory cytokines on cellular … [Pubmed: 31006911] |
Aging Male | Effect of tadalafil on penile nitric oxide synthase and corporal smooth muscle in rats under dutasteride treatment [Pubmed: 32160825] |
J Reconstr Microsurg | Effect of Simvastatin Use in Free Tissue Transfer: An Experimental Study in a Rat Epigastric Free Flap Model [Pubmed: 31995818] |
Biochem Biophys Rep | Slow diffusion on the monolayer culture enhances auto/paracrine effects of Noggin in differentiation of human iPS cells induced by BMP [Pubmed:35005256] |